8-K: NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
10-Q: Quarterly report
20-F/A: Registration statement / Annual report / Transition report (Amendment)
10-Q: Q2 2024 Earnings Report
8-K: NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
8-K: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
10-Q: Quarterly report
NewAmsterdam Pharma | 10-K: FY2023 Annual Report
NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
NewAmsterdam Pharma | 20-F: Registration statement / Annual report / Transition report
NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
NewAmsterdam Pharma | 20-F: Registration statement / Annual report / Transition report
NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Frazier Lifesciences Acquisition Corp | 10-Q: Q3 2022 Earnings Report
Frazier Lifesciences Acquisition Corp | 10-Q: Q2 2022 Earnings Report
Frazier Lifesciences Acquisition Corp | 10-Q: Q1 2022 Earnings Report
Frazier Lifesciences Acquisition Corp | 10-K: FY2021 Annual Report
Frazier Lifesciences Acquisition Corp | 10-Q/A: Q4 2020 Earnings Report
Frazier Lifesciences Acquisition Corp | 10-K/A: Q4 2020 Earnings Report
No Data